Crispr Therapeutics Ag (CRSP)

05:59 AM

Is CRISPR Therapeutics AG stock a contrarian buyJuly 2025 Setups & Community Verified Watchlist Alerts - ulpravda.ru

05:59 AM

05:40 AM

CRISPR Therapeutics AG CFO Sells Shares Under Trading Plan - TradingView — Track All Markets

05:40 AM

04:39 AM

Is CRISPR Therapeutics (CRSP) Using J.P. Morgan Spotlight to Recast Its Gene-Editing Leadership Story? - simplywall.st

04:39 AM

01:17 AM

Can CRISPR Therapeutics AG stock beat market expectations this quarterMarket Weekly Review & Capital Efficiency Focused Strategies - ulpravda.ru

01:17 AM

12:12 PM

Why global investors buy CRISPR Therapeutics AG (1CG) stockMarket Movement Recap & Consistent Income Trade Ideas - ulpravda.ru

12:12 PM

08:37 AM

Institutional Investors Are CRISPR Therapeutics AG's (NASDAQ:CRSP) Biggest Bettors and Were Rewarded After Last Week's US$529m Market Cap Gain - 富途牛牛

08:37 AM

Jan 07, 2026

Crispr Therapeutics AG (CRSP) Gets a Buy from Bank of America Securities - The Globe and Mail

Jan 07, 2026

Jan 07, 2026

Is CRISPR Therapeutics AG stock positioned for long term growthVolatility Index Analysis & Free Discover Dynamic Stocks - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Aug Outlook: Why CRISPR Therapeutics AG (1CG) stock could be next leaderQuarterly Trade Report & Capital Efficient Trading Techniques - moha.gov.vn

Jan 07, 2026

Jan 07, 2026

Is CRISPR Therapeutics (CRSP) Attractively Priced After Recent Gene Editing Progress? - simplywall.st

Jan 07, 2026

Jan 07, 2026

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Jan 07, 2026

Jan 06, 2026

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why - sharewise.com

Jan 06, 2026

Jan 06, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 8.7%Still a Buy? - MarketBeat

Jan 06, 2026

Jan 06, 2026

Chardan maintains a buy recommendation on CRISPR Therapeutics AG (CRSP) - MSN

Jan 06, 2026

Jan 06, 2026

Why CRISPR Therapeutics (CRSP) Soared on Friday? - MSN

Jan 06, 2026

Jan 05, 2026

CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 05, 2026

Jan 05, 2026

Assessing CRISPR Therapeutics (CRSP) Valuation As Investor Interest Returns - simplywall.st

Jan 05, 2026

Jan 02, 2026

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize - Benzinga

Jan 02, 2026

Jan 02, 2026

Crispr Therapeutics: Prospects For 2026Why I Believe Casgevy Is Key (NASDAQ:CRSP) - Seeking Alpha

Jan 02, 2026

Jan 02, 2026

CRISPR Therapeutics AG Stock Analysis and ForecastInsider Trading Compliance & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Jan 02, 2026

Jan 01, 2026

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next - TechStock²

Jan 01, 2026

Dec 31, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com

Dec 31, 2025

Dec 31, 2025

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks - Benzinga

Dec 31, 2025

Dec 31, 2025

Can BEAM's Gene Editing Pipeline Create Long-Term Value Amid Rivalry? - The Globe and Mail

Dec 31, 2025

Dec 31, 2025

Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP) - Finviz

Dec 31, 2025

Dec 30, 2025

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com

Dec 30, 2025

Dec 30, 2025

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock - sharewise.com

Dec 30, 2025

Dec 30, 2025

Discipline and Rules-Based Execution in CRSP Response - Stock Traders Daily

Dec 30, 2025

Dec 30, 2025

Contrarius Global Equity Fund’s Thoughts on CRISPR Therapeutics’ (CRSP) Gene Editing Therapy - Insider Monkey

Dec 30, 2025

Dec 28, 2025

CRISPR Therapeutics Reports Strong 90% Response Rate and Lupus Remission in Landmark Zugo-Cel Update - Finviz

Dec 28, 2025

Dec 28, 2025

CRISPR Therapeutics reports strong 90% response rate and lupus remission in landmark Zugo-Cel update - MSN

Dec 28, 2025

Dec 28, 2025

CRISPR Therapeutics Stock (CRSP) in December 2025: Price, Forecast, CASGEVY Growth and Takeover Rumors - ts2.tech

Dec 28, 2025

Dec 27, 2025

CRISPR Therapeutics AG (CRSP) Stock: ARK Invest Adds Shares as Wall Street Weighs Zugo‑cel Data, Insider Sale, and 2026 Catalysts - ts2.tech

Dec 27, 2025

Dec 26, 2025

Cathie Wood’s ARK boosts CRISPR stock with significant buy - Investing.com

Dec 26, 2025

Dec 26, 2025

CRISPR Therapeutics (CRSP) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat

Dec 26, 2025

Dec 26, 2025

These 2 Healthcare Stocks Beat the Market in 2025. Should You Buy Them in 2026? - Finviz

Dec 26, 2025

Dec 25, 2025

CRISPR Therapeutics (CRSP): Reassessing Valuation After Positive Zugo‑cel Data and New Eli Lilly Collaboration - simplywall.st

Dec 25, 2025

Dec 24, 2025

Is CRISPR Therapeutics stock yesterday's news? - MSN

Dec 24, 2025

Dec 24, 2025

Is CRISPR Therapeutics Stock Yesterday's News? - Finviz

Dec 24, 2025

Dec 23, 2025

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com

Dec 23, 2025

Dec 23, 2025

CRISPR Therapeutics AG (CRSP) stock falls amid market uptick: What investors need to know - MSN

Dec 23, 2025

Dec 23, 2025

Citizens Reiterates CRISPR Therapeutics (CRSP) Market Outperform Recommendation - Nasdaq

Dec 23, 2025

Dec 23, 2025

Crispr Therapeutics Insider Sold Shares Worth $559,549, According to a Recent SEC Filing - marketscreener.com

Dec 23, 2025

Dec 23, 2025

CRISPR Therapeutics (CRSP) CFO reports 10,000-share sale in Form 4 - Stock Titan

Dec 23, 2025

Dec 23, 2025

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - Finviz

Dec 23, 2025

Dec 23, 2025

CRSP Maintains Market Outperform Rating: Latest Analyst Insights | CRSP Stock News - GuruFocus

Dec 23, 2025

Dec 23, 2025

CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies - Finviz

Dec 23, 2025